<DOC>
	<DOCNO>NCT00637884</DOCNO>
	<brief_summary>This single-center , prospective , randomize , double-blind , placebo-controlled , two-way crossover study . A live cat challenge model use expose subject Fel d1 . Subjects test positive cat allergy symptom prim cat exposure challenge eligible enter treatment phase study . Baseline efficacy measure obtain prior dispense study medication treatment period . Cat challenge initiate 1.5 hour follow treatment study medication .</brief_summary>
	<brief_title>A Single-Center , Randomized , Double-Blind , Placebo-Controlled , Two-Way Crossover Study Designed Evaluate Efficacy Fexofenadine HCl 180 mg Preventing Controlling Cat Allergy Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Male female subject , age 12 year old , inclusive History catinduced allergic rhinitis least 2 year , require use allergy medication result avoidance cat Skin test positive cat allergen screening , define wheal great onehalf diameter histamine control least 3 mm large diameter glycerinsaline solution control . A skin test perform previous 15 month may use qualify subject perform investigator 's site record subject 's medical record FEV1 great equal 80 % predict value screen assessment , baseline assessment prior prim cat challenge ( ) . After prim cat challenge , FEV1 must decrease &gt; 12 % prechallenge test % predict value Reversibility &lt; 12 % absolute FEV1 follow 2 puff albuterol screen Minimal baseline allergic symptom , define TSS le equal 4 baseline assessment prior prim cat challenge All female must negative urine pregnancy test Willing able adhere visit schedule study requirement Mild moderate allergic symptom define TSS le equal 8 screen Asthma require treatment medication inhale , shortacting betaagonists ( take within 6 hour prior prim visit ( ) Visits 3 4 ) asthma know exacerbated exposure Fel d1 . ( Subjects exerciseinduced asthma allow . ) Requires medication rhinitis withheld Has cat home ( Subjects cat exclusively outdoors allow . ) Upper respiratory infection within 4 week study entry History severe reaction cat exposure selfreport ( severe define unable tolerate cat exposure least 30 minute ) Acute chronic sinusitis nasal disease result nasal obstruction ( e.g. , nasal septum deviation , nasal polyp ) within 4 week study entry Known hypersensitivity fexofenadine HCl drug similar chemical structure Clinically significant ECG value , judgment investigator , would clinical implication subject 's participation study Clinically significant medical condition ( cardiovascular , hepatic , neurologic , hematological , renal , gastrointestinal , endocrine , major systemic disease ) , , judgment investigator , might interfere study , require treatment make implementation protocol interpretation study result difficult Pregnant breastfeeding Likely require treatment study period drug permit study protocol Immunotherapy , except constant dose immunotherapy maintain throughout study Treatment investigational agent device within 30 day prior study entry Recent history alcohol drug abuse Mental condition render subject unable understand nature , scope , possible consequence study Unlikely comply protocol ( e.g. , uncooperative attitude , unlikely complete study ) Subjects research employee relatives study site staff involve study read protocol</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>